{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:06:36Z","timestamp":1793322396427,"version":"4.5.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jbc.2024.107594","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T19:01:56Z","timestamp":1721329316000},"page":"107594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Drug metabolism of ciprofloxacin, ivacaftor, and raloxifene by Pseudomonas aeruginosa cytochrome P450 CYP107S1"],"prefix":"10.1016","volume":"300","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8059-8035","authenticated-orcid":false,"given":"Sylvie E.","family":"Kandel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0018-3658","authenticated-orcid":false,"given":"Brian C.","family":"Tooker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0794-2263","authenticated-orcid":false,"given":"Jed N.","family":"Lampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.107594_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrmicro.2016.17","article-title":"The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism","volume":"14","author":"Spanogiannopoulos","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jbc.2024.107594_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/science.aag2770","article-title":"Chemical transformation of xenobiotics by the human gut microbiota","volume":"356","author":"Koppel","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107594_bib3","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107594_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/1040841X.2010.481763","article-title":"Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa","volume":"36","author":"Zhao","year":"2010","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.jbc.2024.107594_bib5","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1021\/acsinfecdis.3c00452","article-title":"Investigating the role of metabolism for antibiotic combination therapies in Pseudomonas aeruginosa","volume":"9","author":"Golden","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jbc.2024.107594_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41570-023-00472-3","article-title":"The implication of Mycobacterium tuberculosis-mediated metabolism of targeted xenobiotics","volume":"7","author":"Singh","year":"2023","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.jbc.2024.107594_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fcimb.2014.00029","article-title":"Shifting the paradigm from pathogens to pathobiome: new concepts in the light of meta-omics","volume":"4","author":"Vayssier-Taussat","year":"2014","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.jbc.2024.107594_bib8","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.tree.2019.07.012","article-title":"The pathobiome in animal and plant diseases","volume":"34","author":"Bass","year":"2019","journal-title":"Trends Ecol. Evol."},{"key":"10.1016\/j.jbc.2024.107594_bib9","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1111\/j.1469-0691.1999.tb00719.x","article-title":"Patterns and modes of beta-lactam resistance in Pseudomonas aeruginosa","volume":"5","author":"Pechere","year":"1999","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jbc.2024.107594_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.665759","article-title":"The building blocks of antimicrobial resistance in Pseudomonas aeruginosa: implications for current resistance-breaking therapies","volume":"11","author":"Langendonk","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.jbc.2024.107594_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fcimb.2017.00039","article-title":"Pseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistence","volume":"7","author":"Moradali","year":"2017","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.jbc.2024.107594_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gendis.2019.04.001","article-title":"Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review","volume":"6","author":"Pachori","year":"2019","journal-title":"Genes Dis."},{"key":"10.1016\/j.jbc.2024.107594_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00111-15","article-title":"Effect of human burn wound exudate on Pseudomonas aeruginosa virulence","author":"Gonzalez","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.jbc.2024.107594_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00138-18","article-title":"Cystic fibrosis and Pseudomonas aeruginosa: the host-microbe interface","volume":"32","author":"Malhotra","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jbc.2024.107594_bib15","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1007\/s00134-013-3088-4","article-title":"Clinical implications of antibiotic pharmacokinetic principles in the critically ill","volume":"39","author":"Udy","year":"2013","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jbc.2024.107594_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ppul.23638","article-title":"Individual pharmacokinetic variation leads to underdosing of ciprofloxacin in some cystic fibrosis patients","volume":"52","author":"Schultz","year":"2017","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.jbc.2024.107594_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/17425255.2021.1836157","article-title":"The pharmacokinetics of antibiotics in cystic fibrosis","volume":"17","author":"Akkerman-Nijland","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jbc.2024.107594_bib18","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-3476(84)80317-0","article-title":"Cloxacillin absorption and disposition in cystic fibrosis","volume":"105","author":"Spino","year":"1984","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.jbc.2024.107594_bib19","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/clpt.1990.83","article-title":"Altered disposition of fleroxacin in patients with cystic fibrosis","volume":"47","author":"Mimeault","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2024.107594_bib20","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ejps.2018.07.054","article-title":"First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers","volume":"123","author":"Jiao","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jbc.2024.107594_bib21","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1002\/ppul.23505","article-title":"Therapeutic challenges posed by critical drug-drug interactions in cystic fibrosis","volume":"51","author":"Jordan","year":"2016","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.jbc.2024.107594_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/adc.77.3.239","article-title":"Enhanced drug metabolism in young children with cystic fibrosis","volume":"77","author":"Parker","year":"1997","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.jbc.2024.107594_bib23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/clpt.1988.147","article-title":"Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease","volume":"44","author":"Knoppert","year":"1988","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2024.107594_bib24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nature13684","article-title":"AhR sensing of bacterial pigments regulates antibacterial defence","volume":"512","author":"Moura-Alves","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107594_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw1629","article-title":"Host monitoring of quorum sensing during Pseudomonas aeruginosa infection","volume":"366","author":"Moura-Alves","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107594_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00524-19","article-title":"Regulation of AmpC-driven beta-Lactam resistance in Pseudomonas aeruginosa: different pathways, different signaling","author":"Torrens","year":"2019","journal-title":"mSystems"},{"key":"10.1016\/j.jbc.2024.107594_bib27","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1006\/bbrc.1994.2388","article-title":"Flavin supported fatty acid oxidation by the heme domain of Bacillus megaterium cytochrome P450BM-3","volume":"203","author":"Gonvindaraj","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2024.107594_bib28","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.1074\/jbc.M806864200","article-title":"Yas3p, an Opi1 family transcription factor, regulates cytochrome P450 expression in response to n-alkanes in Yarrowia lipolytica","volume":"284","author":"Hirakawa","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107594_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00826-21","article-title":"Hexabromocyclododecanes are dehalogenated by CYP168A1 from Pseudomonas aeruginosa strain HS9","volume":"87","author":"Huang","year":"2021","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.jbc.2024.107594_bib30","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1128\/AEM.03227-12","article-title":"Bacterial cytochrome P450 system catabolizing the Fusarium toxin deoxynivalenol","volume":"79","author":"Ito","year":"2013","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.jbc.2024.107594_bib31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1039\/C7NP00063D","article-title":"Unrivalled diversity: the many roles and reactions of bacterial cytochromes P450 in secondary metabolism","volume":"35","author":"Greule","year":"2018","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.jbc.2024.107594_bib32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/cbic.201300167","article-title":"Cloning and heterologous expression of the aurachin RE biosynthesis gene cluster afford a new cytochrome P450 for quinoline N-hydroxylation","volume":"14","author":"Kitagawa","year":"2013","journal-title":"ChemBioChem."},{"key":"10.1016\/j.jbc.2024.107594_bib33","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1021\/bi00775a017","article-title":"Camphor binding by Pseudomonas putida cytochrome P-450. Kinetics and thermodynamics of the reaction","volume":"11","author":"Griffin","year":"1972","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107594_bib34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1365-2958.2010.07243.x","article-title":"Mycobacterium tuberculosis CYP125A1, a steroid C27 monooxygenase that detoxifies intracellularly generated cholest-4-en-3-one","volume":"77","author":"Ouellet","year":"2010","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jbc.2024.107594_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101629","article-title":"Pseudomonas aeruginosa cytochrome P450 CYP168A1 is a fatty acid hydroxylase that metabolizes arachidonic acid to the vasodilator 19-HETE","volume":"298","author":"Tooker","year":"2022","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107594_bib36","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.tiv.2007.07.009","article-title":"The metabolic activation of 2-aminofluorine, 4-aminobiphenyl, and benzidine by cytochrome P-450-107S1 of Pseudomonas aeruginosa","volume":"21","author":"Adris","year":"2007","journal-title":"Toxicol. Vitro."},{"key":"10.1016\/j.jbc.2024.107594_bib37","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1096\/fasebj.2021.35.S1.02588","article-title":"Expression and characterization of P.\u00a0aeruginosa cytochrome P450 CYP168A1","volume":"35","author":"Tooker","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2024.107594_bib38","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1089\/mdr.2016.0196","article-title":"From breast cancer to antimicrobial: combating extremely resistant Gram-negative \"Superbugs\" using novel combinations of polymyxin B with selective estrogen receptor modulators","volume":"23","author":"Hussein","year":"2017","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.jbc.2024.107594_bib39","doi-asserted-by":"crossref","first-page":"e02272-18","DOI":"10.1128\/mBio.02272-18","article-title":"Repurposing estrogen receptor antagonists for the treatment of infectious disease","volume":"9","author":"Montoya","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.jbc.2024.107594_bib40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1566524019666191014112133","article-title":"Selective estrogen receptor modulators (SERMs): mechanistic insights against microbial infections","volume":"20","author":"Garg","year":"2020","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.jbc.2024.107594_bib41","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2217\/fmb-2020-0310","article-title":"Selective estrogen receptor modulators against Gram-positive and Gram-negative bacteria: an experimental study","volume":"16","author":"Garg","year":"2021","journal-title":"Future Microbiol."},{"key":"10.1016\/j.jbc.2024.107594_bib42","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijantimicag.2012.05.009","article-title":"Raloxifene attenuates Pseudomonas aeruginosa pyocyanin production and virulence","volume":"40","author":"Ho Sui","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jbc.2024.107594_bib43","series-title":"Raloxifene Analogs as Potential Inhibitors of Pyocyanin Synthesis by Pseudomonas aeruginosa [Abstract]","author":"Thiemann","year":"2022"},{"key":"10.1016\/j.jbc.2024.107594_bib44","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","article-title":"The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature","volume":"239","author":"Omura","year":"1964","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107594_bib45","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00216-008-2244-0","article-title":"Substrate binding to cytochromes P450","volume":"392","author":"Isin","year":"2008","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jbc.2024.107594_bib46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.abb.2011.04.008","article-title":"The kinetic mechanism for cytochrome P450 metabolism of type II binding compounds: evidence supporting direct reduction","volume":"511","author":"Pearson","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jbc.2024.107594_bib47","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/1753465813502115","article-title":"Ivacaftor treatment of cystic fibrosis patients with the G551D mutation: a review of the evidence","volume":"7","author":"Kotha","year":"2013","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.jbc.2024.107594_bib48","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/ph16030410","article-title":"Elexacaftor-tezacaftor-ivacaftor: a life-Ccanging triple combination of CFTR modulator drugs for cystic fibrosis","volume":"16","author":"Bacalhau","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jbc.2024.107594_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/FPC.0000000000000246","article-title":"PharmGKB summary: ivacaftor pathway, pharmacokinetics\/pharmacodynamics","volume":"27","author":"Fohner","year":"2017","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.jbc.2024.107594_bib50","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3109\/00498254.2012.662306","article-title":"Free radical metabolism of raloxifene in human liver microsomes","volume":"42","author":"Lim","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jbc.2024.107594_bib51","doi-asserted-by":"crossref","first-page":"12111","DOI":"10.1073\/pnas.95.21.12111","article-title":"A\u00a0gene cluster for macrolide antibiotic biosynthesis in Streptomyces venezuelae: architecture of metabolic diversity","volume":"95","author":"Xue","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107594_bib52","doi-asserted-by":"crossref","first-page":"W363","DOI":"10.1093\/nar\/gky473","article-title":"CASTp 3.0: computed atlas of surface topography of proteins","volume":"46","author":"Tian","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2024.107594_bib53","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/cmi.12308","article-title":"Defining dysbiosis and its influence on host immunity and disease","volume":"16","author":"Petersen","year":"2014","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.jbc.2024.107594_bib54","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/SHK.0000000000000534","article-title":"The shift of an intestinal \"microbiome\" to a \"pathobiome\" governs the course and outcome of sepsis following surgical injury","volume":"45","author":"Krezalek","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.jbc.2024.107594_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MBP-0002-2014","article-title":"Metabolic adaptations of intracellullar bacterial pathogens and their mammalian host cells during infection (\"Pathometabolism\")","author":"Eisenreich","year":"2015","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.jbc.2024.107594_bib56","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An overview of the antimicrobial resistance mechanisms of bacteria","volume":"4","author":"Reygaert","year":"2018","journal-title":"AIMS Microbiol."},{"key":"10.1016\/j.jbc.2024.107594_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41579-019-0303-5","article-title":"Bacterial survival: evolve and adapt or perish","volume":"18","author":"Chaguza","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jbc.2024.107594_bib58","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3390\/pathogens12040541","article-title":"Role of metabolic adaptation of Streptococcus suis to host niches in bacterial fitness and virulence","volume":"12","author":"Dresen","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.jbc.2024.107594_bib59","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1128\/AAC.05708-11","article-title":"SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis","volume":"56","author":"Tahlan","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jbc.2024.107594_bib60","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.3390\/ijms21207683","article-title":"Hydroxylation of antitubercular drug candidate, SQ109, by mycobacterial cytochrome P450","volume":"21","author":"Bukhdruker","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.107594_bib61","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/AAC.00060-06","article-title":"Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa","volume":"50","author":"Kaye","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jbc.2024.107594_bib62","first-page":"1386","article-title":"Prevalence and fluoroquinolone resistance of Pseudomonas aeruginosa in a hospital of South China","volume":"8","author":"Yang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.jbc.2024.107594_bib63","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/jamp.2013.1056","article-title":"Safety and pharmacokinetics of ciprofloxacin dry powder for inhalation in cystic fibrosis: a phase I, randomized, single-dose, dose-escalation study","volume":"28","author":"Stass","year":"2015","journal-title":"J.\u00a0Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.jbc.2024.107594_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.729828","article-title":"Post-translational modifications of FXR; implications for cholestasis and obesity-related disorders","volume":"12","author":"Appelman","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jbc.2024.107594_bib65","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1359-6446(04)03072-7","article-title":"Implications of the allosteric kinetics of cytochrome P450s","volume":"9","author":"Atkins","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jbc.2024.107594_bib66","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1021\/bi7013807","article-title":"Nile Red is a fluorescent allosteric substrate of cytochrome P450 3A4","volume":"47","author":"Lampe","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107594_bib67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pharmthera.2009.05.011","article-title":"Cooperative properties of cytochromes P450","volume":"124","author":"Denisov","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2024.107594_bib68","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1021\/acs.biochem.8b01268","article-title":"Allosteric interactions in human cytochrome P450 CYP3A4: the role of phenylalanine 213","volume":"58","author":"Denisov","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107594_bib69","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1021\/acs.biochem.9b01001","article-title":"Dynamics and location of the allosteric midazolam site in cytochrome P4503A4 in lipid nanodiscs","volume":"59","author":"Redhair","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107594_bib70","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.1074\/jbc.M610346200","article-title":"Multiple sequential steps involved in the binding of inhibitors to cytochrome P450 3A4","volume":"282","author":"Isin","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107594_bib71","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/187231209789352085","article-title":"Revisiting the metabolism of ketoconazole using accurate mass","volume":"3","author":"Fitch","year":"2009","journal-title":"Drug Metab. Lett."},{"key":"10.1016\/j.jbc.2024.107594_bib72","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1073\/pnas.051551698","article-title":"The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity","volume":"98","author":"Staudinger","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107594_bib73","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0099-5428(04)31006-3","article-title":"Ciprofloxacin: drug metabolism and pharmacokinetic profile","volume":"31","author":"Al-Omar","year":"2005","journal-title":"Profiles Drug Subst. Excip. Relat. Methodol."},{"key":"10.1016\/j.jbc.2024.107594_bib74","first-page":"1417","article-title":"Transfer of ciprofloxacin to bile and determination of biliary metabolites in humans","volume":"36","author":"Tanimura","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jbc.2024.107594_bib75","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0378-4347(00)82086-1","article-title":"Determination of the new fluoroquinolone fleroxacin and its N-demethyl and N-oxide metabolites in plasma and urine by high-performance liquid chromatography with fluorescence detection","volume":"527","author":"Heizmann","year":"1990","journal-title":"J.\u00a0Chromatogr."},{"key":"10.1016\/j.jbc.2024.107594_bib76","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0039-9140(02)00245-X","article-title":"Determination of levofloxacin in human urine by adsorptive square-wave anodic stripping voltammetry on a glassy carbon electrode","volume":"58","author":"Radi","year":"2002","journal-title":"Talanta"},{"key":"10.1016\/j.jbc.2024.107594_bib77","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fped.2019.00154","article-title":"Placental ESRRG-CYP19A1 expressions and circulating 17-beta estradiol in IUGR pregnancies","volume":"7","author":"Anelli","year":"2019","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.jbc.2024.107594_bib78","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/jama.2023.8120","article-title":"Cystic fibrosis: a review","volume":"329","author":"Ong","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jbc.2024.107594_bib79","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1945892418815615","article-title":"Ivacaftor, a cystic fibrosis transmembrane conductance regulator potentiator, enhances ciprofloxacin activity against Pseudomonas aeruginosa","volume":"33","author":"Cho","year":"2019","journal-title":"Am. J. Rhinol. Allergy"},{"key":"10.1016\/j.jbc.2024.107594_bib80","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03148-21","article-title":"Combining ivacaftor and intensive antibiotics achieves limited clearance of cystic fibrosis infections","volume":"12","author":"Durfey","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.jbc.2024.107594_bib81","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1124\/dmd.107.018663","article-title":"A\u00a0combined model for predicting CYP3A4 clinical net drug-drug interaction based on CYP3A4 inhibition, inactivation, and induction determined in\u00a0vitro","volume":"36","author":"Fahmi","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jbc.2024.107594_bib82","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/ppul.26093","article-title":"Plasma and cellular ivacaftor concentrations in patients with cystic fibrosis","volume":"57","author":"Guimbellot","year":"2022","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.jbc.2024.107594_bib83","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fcimb.2019.00193","article-title":"Drug repurposing to fight colistin and carbapenem-resistant bacteria","volume":"9","author":"Peyclit","year":"2019","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.jbc.2024.107594_bib84","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.3390\/pathogens11121420","article-title":"Drug repurposing approaches towards defeating multidrug-resistant Gram-negative pathogens: novel polymyxin\/non-antibiotic combinations","volume":"11","author":"Koh Jing Jie","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.jbc.2024.107594_bib85","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/00003495-199957050-00001","article-title":"Selective estrogen receptor modulators: a look ahead","volume":"57","author":"Mitlak","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.jbc.2024.107594_bib86","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.abb.2011.06.016","article-title":"Formation of raloxifene homo-dimer in CYP3A4, evidence for multi-substrate binding in a single catalytically competent P450 active site","volume":"513","author":"Davis","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jbc.2024.107594_bib87","doi-asserted-by":"crossref","first-page":"D646","DOI":"10.1093\/nar\/gkv1227","article-title":"Enhanced annotations and features for comparing thousands of Pseudomonas genomes in the Pseudomonas genome database","volume":"44","author":"Winsor","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2024.107594_bib88","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1479-7364-4-1-59","article-title":"The cytochrome P450 homepage","volume":"4","author":"Nelson","year":"2009","journal-title":"Hum. Genomics."},{"key":"10.1016\/j.jbc.2024.107594_bib89","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2144\/00286ir01","article-title":"The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences","volume":"28","author":"Stothard","year":"2000","journal-title":"Biotechniques"},{"key":"10.1016\/j.jbc.2024.107594_bib90","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1073\/pnas.88.13.5597","article-title":"Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli","volume":"88","author":"Barnes","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107594_bib91","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2024.107594_bib92","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jbc.2024.107594_bib93","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J.\u00a0Comput. Chem."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824020957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824020957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T03:22:24Z","timestamp":1728098544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925824020957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":93,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0021925824020957"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107594","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug metabolism of ciprofloxacin, ivacaftor, and raloxifene by Pseudomonas aeruginosa cytochrome P450 CYP107S1","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"107594"}}